布罗卢齐祖马布与阿弗利伯塞普特在患有糖尿病黄斑的患者中:随机对照试验的元分析
Leonardo B Justino1, Gustavo B Justino1, Fabrissio P Graffunder2
1Division of Medicine, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Clinical ophthalmology (Auckland, N.Z.)
|December 16, 2024
概括
与糖尿病黄斑 (DME) 的aflibercept相比,布罗卢齐祖马布在视觉敏度和解剖结果上的优越性显示出非劣势. 需要进行进一步的试验,以充分评估DME治疗的安全性.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学研究 药理学研究
背景情况:
- 糖尿病黄斑 (DME) 是糖尿病患者视力丧失的主要原因.
- 目前对DME的治疗包括抗血管内皮生长因子 (抗VEGF) 疗法.
- 布罗卢齐祖马布和阿弗利伯塞普是用于治疗视网膜疾病的抗VEGF药物.
研究的目的:
- 为了比较brolucizumab与aflibercept在糖尿病黄斑 (DME) 患者的疗效和安全性.
- 进行系统性审查和元分析,并进行试验顺序分析 (TSA),以评估治疗结果.
主要方法:
- 3项随机对照试验 (RCT) 的系统综述和元分析,包括1253名患有DME的患者.
- 在Embase,Cochrane和PubMed数据库中搜索到2024年2月16日.
- 试验顺序分析 (TSA) 用于评估安全结果的统计确定性.
主要成果:
- 在最佳校正视敏度 (BCVA) 变化 (LSMD 0.29,p=0.73) 中,布罗卢齐祖马布与阿弗利塞普特无差.
- 与aflibercept相比,布罗卢齐祖马布在中央子场厚度 (CST) 中显著减少 (LSMD -24.5μm,p<0.05).
- 眼部不良事件 (AE) 和特别关注的不良事件 (AESI) 的发生率在两种治疗方法之间没有显著差异.
结论:
- 与aflibercept相比,布罗卢齐祖马布在DME治疗的功能结果方面不劣,在解剖结果方面优于aflibercept.
- 虽然眼睛AEs和AESIs的数量很低,并且在统计学上没有显著性,但进一步的大规模RCT是有必要的.
- 这些发现凸显了需要进行更强大的研究,以最终确定布罗卢齐祖马布在DME管理中的安全性.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.0K
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
